Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

S. African insurers may fund vaccines for broader population

by AIP Online Bureau | Jan 5, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

  South African medical-insurance companies, business organizations and the government are developing a program in which the private sector will help fund Covid-19 vaccines for people not covered by insurance. Legislation has been amended to allow the companies...

Aviation reinsurance rates rise by up to 250% – report

by AIP Online Bureau | Jan 5, 2021 | Eco/Invest/Demography, International News, Non-Life, Reinsurance

LONDON: Aviation reinsurance rates rose by up to 250% at the key Jan. 1 renewal date, broker Willis Re said in a report on Monday, with the market still reeling from the impact of Boeing 737 MAX crashes two years ago.The 737 MAX resumed commercial flights in the...

AM Best ranks UnitedHealth Group and Allianz SE as world’s largest insurers

by AIP Online Bureau | Jan 5, 2021 | International News, Life, Non-Life

OLDWICK, N.J: UnitedHealth Group Incorporated occupied the top spot in AM Best’s ranking of the world’s 25 largest insurance companies for a sixth straight year, with $189.7 billion in net premiums written (NPW) in 2019. In addition, Allianz SE and...

SC upholds environmental clearance, govt notification on Central Vista

by AIP Online Bureau | Jan 5, 2021 | Climate, Environment, Renewable Energy, Eco/Invest/Demography, Indian News

New Delhi: In a majority verdict, the Supreme Court on Tuesday upheld theenvironmental clearance and notification for change in land use for the Central Vista Project. The Central Vista revamp, announced in September, 2019 envisages a new triangular Parliament...

BMS launches ASIA operations

by AIP Online Bureau | Jan 5, 2021 | Intermediaries, International News, Non-Life, Reinsurance

  Singapore: BMS Group Limited (“BMS”), the independent specialist insurance and reinsurance broker, today announces the launch of its Asia broking operations, headquartered in Singapore and with proposed operations in Hong Kong pending regulatory...

Jack Ma’s disappearing act fuels speculation about billionaire’s whereabouts

by AIP Online Bureau | Jan 5, 2021 | Eco/Invest/Demography, International News, Risk Management, Technology

  BEIJING: Alibaba founder Jack Ma’s absence from public view in the past two months, including missing the final episode of a TV show on which he was to appear as a judge, has fueled social media speculation over his whereabouts amid a Chinese regulatory...

Germany mulls delaying second COVID-19 vaccine shot, Denmark approves delay

by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Health, International News, Non-Life

  BERLIN/COPENHAGEN: Germany was weighing on Monday whether to allow a delay in administering a second dose of the COVID-19 vaccine from BioNTech and Pfizer to make scarce supplies go further, after a similar move by Britain last week. Syringes are prepared for...

Wildlife, land-use change and health infra: Scientists identify ways of preventing next pandemic

by AIP Online Bureau | Jan 4, 2021 | Articles, Disaster & Management, Eco/Invest/Demography, Health, Non-Life, Pandemic

  How to prevent the next pandemic? As 2021 begins with Covid-19 continuing its global spread, scientists have spotlighted three approaches to at least reduce the risk of pandemic potential diseases – screening animals, reducing land-use change and...

Sufficient Covid-19 Vaccines For First Phase Of Vaccination Drive: V K Paul

by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Health, Indian News, Pandemic, Policy

New Delhi: India has enough stockpile of the Covid-19 vaccine for inoculation of priority groups, including healthcare workers and frontline workers, in the first phase, Niti Aayog member V K Paul said on Monday. Paul, who is also the Chairman of National Expert Group...

Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII

by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Health, Indian News, Pandemic

Mumbai: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and will be priced at double that rate in private market ones such sales open up, said the CEO of its Indian manufacturer on...
« Older Entries
Next Entries »

Recent Posts

  • Ukraine may provide additional insurance cover for ships to revive seaborne food exports
  • Financial fragmentation could amplify shocks across global insurance markets: Geneva Association report
  • Aon launches CyQu marketplace for better cyber risk management
  • LIC leads $703mn NSE anchor book
  • Florida Hurricane could trigger $300bn insured losses: Swiss Re

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy